296 related articles for article (PubMed ID: 34720749)
21. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis.
Kim MR; Kim AS; Choi HI; Jung JH; Park JY; Ko HJ
PLoS One; 2020; 15(7):e0236445. PubMed ID: 32716955
[TBL] [Abstract][Full Text] [Related]
23. Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis.
Winther-Larsen A; Aggerholm-Pedersen N; Sandfeld-Paulsen B
Syst Rev; 2021 Jan; 10(1):40. PubMed ID: 33509254
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review.
Zhu Y; Zhou S; Liu Y; Zhai L; Sun X
BMC Cancer; 2018 Apr; 18(1):443. PubMed ID: 29669528
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis.
Semeniuk-Wojtaś A; Lubas A; Stec R; Syryło T; Niemczyk S; Szczylik C
Clin Genitourin Cancer; 2018 Jun; 16(3):e685-e693. PubMed ID: 29454639
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma.
Li YJ; Yang X; Zhang WB; Yi C; Wang F; Li P
Cancer Manag Res; 2017; 9():443-451. PubMed ID: 29033609
[TBL] [Abstract][Full Text] [Related]
29. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma.
Xia WK; Liu ZL; Shen D; Lin QF; Su J; Mao WD
World J Surg Oncol; 2016 Apr; 14():127. PubMed ID: 27125872
[TBL] [Abstract][Full Text] [Related]
30. Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis.
Guan Y; Xiong H; Feng Y; Liao G; Tong T; Pang J
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):220-231. PubMed ID: 32034294
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Pretreated Blood Inflammatory Markers in Patients with Bone Sarcoma: A Meta-Analysis.
Jiang M; Ma S; Hua Z; Zhao Z; Gao S
Dis Markers; 2021; 2021():8839512. PubMed ID: 33897913
[TBL] [Abstract][Full Text] [Related]
32. Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: A systematic review and meta-analysis.
Cui H; Li Y; Li S; Liu G
Cancer Med; 2023 Jan; 12(1):99-110. PubMed ID: 35692190
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
34. Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis.
Liu C; Wu J
Front Pediatr; 2022; 10():969502. PubMed ID: 36081627
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of inflammation-related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Cui LJ; Yu FH; Cheng ZX; Su F; Chen YY; Tan HY
J Neuroendocrinol; 2024 Apr; 36(4):e13381. PubMed ID: 38468159
[TBL] [Abstract][Full Text] [Related]
36. Role of systemic inflammation in predicting the prognosis of ampulla of Vater carcinoma.
Seo HK; Hwang DW; Lee JH; Song KB; Shin SH; Kwon J; Lee YJ; Kim SC
Surg Oncol; 2019 Jun; 29():33-40. PubMed ID: 31196491
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities.
Chen Z; Zhao G; Chen F; Xia J; Jiang L
BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein and the neutrophil-to-lymphocyte ratio are prognostic biomarkers in metastatic renal cell carcinoma patients treated with nivolumab.
Suzuki K; Terakawa T; Furukawa J; Harada K; Hinata N; Nakano Y; Fujisawa M
Int J Clin Oncol; 2020 Jan; 25(1):135-144. PubMed ID: 31512006
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.
Xiang Q; Liu Y; Xiao J; Ou L; Du J
Am J Mens Health; 2024; 18(2):15579883241234747. PubMed ID: 38514969
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
